Genome Therapeutics Ltd
Private Limited Company · London
ActiveUnited KingdomIncorporated 2020Private Limited Company
Financial snapshot
Full financialsPeriod ended 2025-06-30GBPcompany accounts
Net assets
£364.84k-£1.34m vs 2024-06-30Cash at bank
£362.94k-£1.11m vs 2024-06-30Turnover
Not availableNot in extracted metricsEmployees
60 vs 2024-06-30Balance sheet
GBP · companyCompany record
- Company number
- 12392992
- Incorporated
- 2020-01-08
- Legal form
- Private Limited Company
- Registered office
- REGENT HOUSE, 316 BEULAH HILL, LONDON, SE19 3HF
- SIC codes
- 23006
People & control
View all6Current role holders0Control records without an end date1Outstanding security records
OfficerOther current roles
Xiangmin Cuidirector
0James Walter Glasheendirector
0Samuel Apariciodirector
0Saul Kleindirector
18Bobby Yerramilli Raodirector
4Dan Mchughdirector
0No control records without an end date are available. Ownership is not established from this alone.
Activity timeline
- Xiangmin Cui appointed
director
- James Walter Glasheen appointed
director
- Samuel Aparicio appointed
director
- Shankar Balasubramanian resigned
director
- Saul Klein appointed
director
- Accounts period ended
GBP · 100 source facts
Connected companies
Open networkNo downstream companies resolved. Upstream control, where available, is shown in the network.
Capital & security
Public records and extracted accounts. Missing figures are unknown, not zero. Research matches are not necessarily direct awards.